Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.54 |
| ▸ | APLNR | P35414 | 3/20 | 0.48 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.47 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.46 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.46 |
| ▸ | TGM2 | P21980 | 1/20 | 0.45 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12415023 | 1.00 | MEN1 (0.57) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL12415012 | 0.93 | MEN1 (0.63) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL12311495 | 0.87 | MEN1 (0.66) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL14351071 | 0.85 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL13232606 | 0.85 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL1083752 | 0.84 | MEN1 (0.68) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL15384907 | 0.84 | MEN1 (0.60) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL860877 | 0.84 | MEN1 (0.72) | MEN1USP2POLBPPARGBLM | |
| SCHEMBL12415038 | 0.84 | MEN1 (0.55) | MEN1USP2POLBPPARGBLM | |
| Water SCHEMBL3843902 | 0.83 | MEN1 (0.67) | MEN1USP2POLBPPARGBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110165065-A1 | MEANS FOR THE DETECTION AND TREATMENT OF PROSTATE CELLS | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) | 2011-07-07 | — | — | US | disclosed |
| WO-2010017986-A1 | MEANS FOR THE DETECTION AND TREATMENT OF PROSTATE CELLS | Eberhard-Karls-Universität Tübingen Universitätsklinikum (DE) | 2010-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110165065-A1 | MEANS FOR THE DETECTION AND TREATMENT OF PROSTATE CELLS | KLK3, ACP3, KLK5 | MEN1 1284/4885USP2 2755/4885POLB 453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.